GILD Competitors & Alternatives
Compare Gilead Sciences Inc with similar stocks in the same industry
Drug Manufacturers - General
GILD
Main Stock$166.89
Tradestie Score
35
Market Cap
$137.92B
Revenue Growth
0.1%
Analyst Upside
+3.4%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$40.31
|
$262.92B | 10.2 | 45 | Compare |
|
AZN
AstraZeneca PLC
|
$186.43
|
$261.56B | 26.4 | 41 | Compare |
|
NVS
Novartis AG
|
$162.55
|
$254.99B | 30.9 | 35 | Compare |
|
MRK
Merck & Co., Inc.
|
$146.73
|
$225.13B | 148.4 | 57 | Compare |
|
AMGN
Amgen Inc
|
$460.42
|
$160.70B | 26.7 | 30 | Compare |
|
PFE
Pfizer Inc.
|
$29.39
|
$154.70B | 42.7 | 50 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.04
|
$121.27B | 23.3 | 28 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$62.14
|
$96.54B | 14.0 | 55 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$50.33
|
$91.59B | 17.6 | 49 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$904.35
|
$63.59B | 20.0 | 35 | Compare |
More GILD Analysis
Data updated: Nov 08, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
17 stocks in this industry